Related Experiment Videos
Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?
1McGill University Health Center/Royal Victoria Hospital, Montreal, Quebec. Jacques.genest@muhc.mcgill.ca
Insights
High-sensitivity C-reactive protein (hsCRP) is a strong cardiovascular risk factor, independently predicting coronary artery disease. Elevated hsCRP may indicate benefits from aspirin or statins, warranting further research.
Area of Science:
- Cardiology
- Inflammation Biology
Background:
- C-reactive protein (CRP) is an inflammatory marker with significant cardiovascular implications.
- High-sensitivity CRP (hsCRP) shows strong, consistent association with atherosclerotic vascular disease, particularly coronary artery disease (CAD).
Purpose of the Study:
- To review the predictive value of hsCRP for cardiovascular disease.
- To evaluate the potential benefits of pharmacological interventions in individuals with elevated hsCRP.
- To identify areas for future research and public health policy development regarding hsCRP measurement.
Main Methods:
- Review of existing data and clinical trials associating hsCRP with cardiovascular disease.
- Multivariate analysis to determine independent predictive value of hsCRP.
- Retrospective analysis of clinical trials on aspirin and statin use in relation to hsCRP levels.
Main Results:
- hsCRP independently predicts coronary artery disease risk alongside conventional factors like age, blood pressure, and cholesterol levels.
- Individuals with elevated hsCRP may benefit from acetylsalicylic acid and/or statin therapy.
- Further research is needed to understand CRP biology and its link to metabolic syndrome and obesity.
Conclusions:
- hsCRP is a valuable independent predictor of cardiovascular risk.
- Pharmacological interventions may benefit individuals with elevated hsCRP, especially in primary prevention settings.
- Future clinical trials are essential to confirm benefits in specific patient groups, such as those with normal LDL-C.
Abstract:
The inflammatory marker C-reactive protein (CRP) is a highly promising cardiovascular risk factor. The data associating high sensitivity CRP (hsCRP) to atherosclerotic vascular disease, especially coronary artery disease, are strong, consistent and have been tested across many populations. Multivariate analysis shows that hsCRP has an independent predictive value to the prediction of coronary artery disease along with the conventional cardiovascular risk factors such as sex, age, cigarette smoking, blood pressure, diabetes, elevated total cholesterol (or low density lipoprotein cholesterol) and high density lipoprotein cholesterol. Retrospective analysis of published clinical trials show that individuals with elevated hsCRP benefit from the use of acetylsalicylic acid and/or the statin class of medication. Before implementing a public health policy that includes the measurement and clinical decision-making algorithm using hsCRP, several conditions must be met. Among them, a better understanding of the biology of CRP, an indepth scrutiny at the link between hsCRP levels, the metabolic syndrome, and abdominal obesity and finally, clinical trials, currently underway that will test the hypothesis that patients with elevated levels of hsCRP but a normal low density lipoprotein-cholesterol benefit from a pharmacological intervention for cardiovascular prevention in a primary prevention setting.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
01:26Atherosclerosis III: Management
01:30Coronary Artery Disease I: Introduction
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:27Coronary Artery Disease V: Interprofessional Care
01:38Inflammation